Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Ensitrelvir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CROI 2025: SCORPIO-PEP Phase 3 Trial: Ensitrelvir Prevents COVID
    CROI 2025: SCORPIO-PEP Phase 3 Trial: Ensitrelvir Prevents COVID

    12 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250311777665/en

    BUSINESSWIRE
    12 Mar 2025
    Share Share
    Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
    Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial

    13 May 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/japans-shionogi-says-covid-treatment-did-not-meet-endpoint-late-stage-trial-2024-05-13/

    REUTERS
    13 May 2024
    Share Share
    Shionogi Presents New Ensitrelvir COVID-19 Data Supporting Effectiveness
    Shionogi Presents New Ensitrelvir COVID-19 Data Supporting Effectiveness

    11 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231010759997/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share
    Shionogi Presents New Ensitrelvir Clinical and Real-World Data
    Shionogi Presents New Ensitrelvir Clinical and Real-World Data

    18 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230918485005/en

    BUSINESSWIRE
    18 Sep 2023
    Share Share
    Seven manufacturers sign sublicence agreements with MPP to produce ensitrelvir
    Seven manufacturers sign sublicence agreements with MPP to produce ensitrelvir

    27 Jun 2023

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/seven-manufacturers-sign-sublicence-agreements-with-the-mpp-to-produce-generic-versions-of-shionogis-covid-19-oral-antiviral-ensitrelvir-14323

    INDIANPHARMAPOST
    27 Jun 2023
    Share Share
    Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment
    Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment

    04 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230404005987/en

    BUSINESSWIRE
    04 Apr 2023
    Share Share